280 related articles for article (PubMed ID: 8636651)
1. Renal expression of a transforming growth factor-alpha transgene accelerates the progression of inherited, slowly progressive polycystic kidney disease in the mouse.
Gattone VH; Kuenstler KA; Lindemann GW; Lu X; Cowley BD; Rankin CA; Calvet JP
J Lab Clin Med; 1996 Feb; 127(2):214-22. PubMed ID: 8636651
[TBL] [Abstract][Full Text] [Related]
2. Transgenic overexpression of prothymosin alpha induces development of polycystic kidney disease.
Li KJ; Shiau AL; Chiou YY; Yo YT; Wu CL
Kidney Int; 2005 May; 67(5):1710-22. PubMed ID: 15840017
[TBL] [Abstract][Full Text] [Related]
3. Transforming growth factor alpha (TGF-alpha) and other targets of tumor necrosis factor-alpha converting enzyme (TACE) in murine polycystic kidney disease.
Nemo R; Murcia N; Dell KM
Pediatr Res; 2005 May; 57(5 Pt 1):732-7. PubMed ID: 15774823
[TBL] [Abstract][Full Text] [Related]
4. The effect of paclitaxel on the progression of polycystic kidney disease in rodents.
Martinez JR; Cowley BD; Gattone VH; Nagao S; Yamaguchi T; Kaneta S; Takahashi H; Grantham JJ
Am J Kidney Dis; 1997 Mar; 29(3):435-44. PubMed ID: 9041221
[TBL] [Abstract][Full Text] [Related]
5. Multiorgan mRNA misexpression in murine autosomal recessive polycystic kidney disease.
Gattone VH; Ricker JL; Trambaugh CM; Klein RM
Kidney Int; 2002 Nov; 62(5):1560-9. PubMed ID: 12371956
[TBL] [Abstract][Full Text] [Related]
6. Renal cysts in transgenic mice expressing transforming growth factor-alpha.
Lowden DA; Lindemann GW; Merlino G; Barash BD; Calvet JP; Gattone VH
J Lab Clin Med; 1994 Sep; 124(3):386-94. PubMed ID: 8083581
[TBL] [Abstract][Full Text] [Related]
7. Polycystic kidney disease in SBM transgenic mice: role of c-myc in disease induction and progression.
Trudel M; Barisoni L; Lanoix J; D'Agati V
Am J Pathol; 1998 Jan; 152(1):219-29. PubMed ID: 9422539
[TBL] [Abstract][Full Text] [Related]
8. A hereditary model of slowly progressive polycystic kidney disease in the mouse.
Takahashi H; Calvet JP; Dittemore-Hoover D; Yoshida K; Grantham JJ; Gattone VH
J Am Soc Nephrol; 1991 Jan; 1(7):980-9. PubMed ID: 1883968
[TBL] [Abstract][Full Text] [Related]
9. Acceleration of polycystic kidney disease progression in cpk mice carrying a deletion in the homeodomain protein Cux1.
Alcalay NI; Sharma M; Vassmer D; Chapman B; Paul B; Zhou J; Brantley JG; Wallace DP; Maser RL; Vanden Heuvel GB
Am J Physiol Renal Physiol; 2008 Dec; 295(6):F1725-34. PubMed ID: 18829740
[TBL] [Abstract][Full Text] [Related]
10. C-myc-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent.
Trudel M; Lanoix J; Barisoni L; Blouin MJ; Desforges M; L'Italien C; D'Agati V
J Exp Med; 1997 Dec; 186(11):1873-84. PubMed ID: 9382886
[TBL] [Abstract][Full Text] [Related]
11. Renal accumulation and excretion of cyclic adenosine monophosphate in a murine model of slowly progressive polycystic kidney disease.
Yamaguchi T; Nagao S; Kasahara M; Takahashi H; Grantham JJ
Am J Kidney Dis; 1997 Nov; 30(5):703-9. PubMed ID: 9370187
[TBL] [Abstract][Full Text] [Related]
12. EGF-related growth factors in the pathogenesis of murine ARPKD.
MacRae Dell K; Nemo R; Sweeney WE; Avner ED
Kidney Int; 2004 Jun; 65(6):2018-29. PubMed ID: 15149315
[TBL] [Abstract][Full Text] [Related]
13. Glycogen synthase kinase-3β promotes cyst expansion in polycystic kidney disease.
Tao S; Kakade VR; Woodgett JR; Pandey P; Suderman ED; Rajagopal M; Rao R
Kidney Int; 2015 Jun; 87(6):1164-75. PubMed ID: 25629553
[TBL] [Abstract][Full Text] [Related]
14. Elevated c-myc protooncogene expression in autosomal recessive polycystic kidney disease.
Cowley BD; Smardo FL; Grantham JJ; Calvet JP
Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8394-8. PubMed ID: 3479800
[TBL] [Abstract][Full Text] [Related]
15. Expression of transforming growth factor alpha and epidermal growth factor receptor in adult polycystic kidney disease.
Lee DC; Chan KW; Chan SY
J Urol; 1998 Jan; 159(1):291-6. PubMed ID: 9400497
[TBL] [Abstract][Full Text] [Related]
16. Genetic identification of two major modifier loci of polycystic kidney disease progression in pcy mice.
Woo DD; Nguyen DK; Khatibi N; Olsen P
J Clin Invest; 1997 Oct; 100(8):1934-40. PubMed ID: 9329956
[TBL] [Abstract][Full Text] [Related]
17. ADAM17 promotes proliferation of collecting duct kidney epithelial cells through ERK activation and increased glycolysis in polycystic kidney disease.
Beck Gooz M; Maldonado EN; Dang Y; Amria MY; Higashiyama S; Abboud HE; Lemasters JJ; Bell PD
Am J Physiol Renal Physiol; 2014 Sep; 307(5):F551-9. PubMed ID: 24899059
[TBL] [Abstract][Full Text] [Related]
18. Methylprednisolone retards the progression of inherited polycystic kidney disease in rodents.
Gattone VH; Cowley BD; Barash BD; Nagao S; Takahashi H; Yamaguchi T; Grantham JJ
Am J Kidney Dis; 1995 Feb; 25(2):302-13. PubMed ID: 7847359
[TBL] [Abstract][Full Text] [Related]
19. Molecular analyses of liver tumors in c-myc transgenic mice and c-myc and TGF-alpha double transgenic mice.
Ohgaki H; Sanderson ND; Ton P; Thorgeirsson SS
Cancer Lett; 1996 Aug; 106(1):43-9. PubMed ID: 8827045
[TBL] [Abstract][Full Text] [Related]
20. Transforming growth factor alpha and epidermal growth factor expression in experimental murine polycystic kidney disease.
Ogborn MR; Sareen S
Pediatr Nephrol; 1996 Apr; 10(2):181-4. PubMed ID: 8703707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
